Reviews Sprix


No reviews yet.

Sprix Drug Description
SPRIX™
(ketorolac tromethamine) Nasal Spray

WARNING
LIMITATIONS OF USE, GASTROINTESTINAL, BLEEDING, CARDIOVASCULAR, and RENAL RISK
Limitations of Use
SPRIX (ketorolac tromethamine), a nonsteroidal anti-inflammatory drug (NSAID),
is indicated for short-term (up to 5 days in adults) management of moderate
to moderately severe pain that requires analgesia at the opioid level. Do not
exceed a total combined duration of use of SPRIX and other ketorolac formulations
(IM/IV or oral) of 5 days [see DOSING AND ADMINISTRATION, and WARNINGS AND PRECAUTIONS].
SPRIX is not indicated for use in pediatric patients and it is not indicated
for minor or chronic painful conditions.
Gastrointestinal Risk
Ketorolac tromethamine, including SPRIX, can cause peptic ulcers, gastrointestinal
bleeding and/or perforation of the stomach or intestines, which can be fatal.
These events can occur at any time during use and without warning symptoms.
Therefore, SPRIX is contraindicated in patients with active peptic ulcer disease,
in patients with recent gastrointestinal bleeding or perforation, and in patients
with a history of peptic ulcer disease or gastrointestinal bleeding. Elderly
patients are at greater risk for serious gastrointestinal events [see CONTRAINDICATIONS,
WARNINGS AND PRECAUTIONS].
Bleeding Risk
Ketorolac tromethamine inhibits platelet function and is, therefore, contraindicated
in patients with suspected or confirmed cerebrovascular bleeding, patients with
hemorrhagic diathesis, incomplete hemostasis and those at high risk of bleeding
[see CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS].
Cardiovascular Risk
NSAIDs may cause an increased risk of serious cardiovascular thrombotic events,
myocardial infarction, and stroke, which can be fatal. This risk may increase
with duration of use. Patients with cardiovascular disease or risk factors for
cardiovascular disease may be at greater risk [see WARNINGS AND PRECAUTIONS].
SPRIX Nasal spray is contraindicated for treatment of peri-operative
pain in the setting of coronary artery bypass graft (CABG) surgery [see CONTRAINDICATIONS].
Renal Risk
SPRIX is contraindicated in patients with advanced renal impairment
and in patients at risk for renal failure due to volume depletion [see CONTRAINDICATIONS,
WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION
Ketorolac tromethamine is a member of the pyrrolo-pyrrole group of nonsteroidal
anti-inflammatory drugs (NSAIDs). The chemical name for ketorolac tromethamine
is (±)-5-benzoyl-2,3-dihydro-1Hpyrrolizine-1-carboxylic acid, compound
with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), and the structural formula
is:








The molecular weight of ketorolac tromethamine is 376.41. Ketorolac tromethamine
is highly water-soluble, allowing its formulation in an aqueous nasal spray
product at pH 7.2.
SPRIX is available as an intranasal spray product containing the active ingredient
(ketorolac tromethamine) and the excipients edetate disodium (EDTA), monobasic
potassium phosphate, sodium hydroxide, and water for injection.
Last reviewed on RxList: 6/14/2010




Sprix Drug Description
SPRIX™
(ketorolac tromethamine) Nasal Spray

WARNING
LIMITATIONS OF USE, GASTROINTESTINAL, BLEEDING, CARDIOVASCULAR, and RENAL RISK
Limitations of Use
SPRIX (ketorolac tromethamine), a nonsteroidal anti-inflammatory drug (NSAID),
is indicated for short-term (up to 5 days in adults) management of moderate
to moderately severe pain that requires analgesia at the opioid level. Do not
exceed a total combined duration of use of SPRIX and other ketorolac formulations
(IM/IV or oral) of 5 days [see DOSING AND ADMINISTRATION, and WARNINGS AND PRECAUTIONS].
SPRIX is not indicated for use in pediatric patients and it is not indicated
for minor or chronic painful conditions.
Gastrointestinal Risk
Ketorolac tromethamine, including SPRIX, can cause peptic ulcers, gastrointestinal
bleeding and/or perforation of the stomach or intestines, which can be fatal.
These events can occur at any time during use and without warning symptoms.
Therefore, SPRIX is contraindicated in patients with active peptic ulcer disease,
in patients with recent gastrointestinal bleeding or perforation, and in patients
with a history of peptic ulcer disease or gastrointestinal bleeding. Elderly
patients are at greater risk for serious gastrointestinal events [see CONTRAINDICATIONS,
WARNINGS AND PRECAUTIONS].
Bleeding Risk
Ketorolac tromethamine inhibits platelet function and is, therefore, contraindicated
in patients with suspected or confirmed cerebrovascular bleeding, patients with
hemorrhagic diathesis, incomplete hemostasis and those at high risk of bleeding
[see CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS].
Cardiovascular Risk
NSAIDs may cause an increased risk of serious cardiovascular thrombotic events,
myocardial infarction, and stroke, which can be fatal. This risk may increase
with duration of use. Patients with cardiovascular disease or risk factors for
cardiovascular disease may be at greater risk [see WARNINGS AND PRECAUTIONS].
SPRIX Nasal spray is contraindicated for treatment of peri-operative
pain in the setting of coronary artery bypass graft (CABG) surgery [see CONTRAINDICATIONS].
Renal Risk
SPRIX is contraindicated in patients with advanced renal impairment
and in patients at risk for renal failure due to volume depletion [see CONTRAINDICATIONS,
WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION
Ketorolac tromethamine is a member of the pyrrolo-pyrrole group of nonsteroidal
anti-inflammatory drugs (NSAIDs). The chemical name for ketorolac tromethamine
is (±)-5-benzoyl-2,3-dihydro-1Hpyrrolizine-1-carboxylic acid, compound
with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), and the structural formula
is:








The molecular weight of ketorolac tromethamine is 376.41. Ketorolac tromethamine
is highly water-soluble, allowing its formulation in an aqueous nasal spray
product at pH 7.2.
SPRIX is available as an intranasal spray product containing the active ingredient
(ketorolac tromethamine) and the excipients edetate disodium (EDTA), monobasic
potassium phosphate, sodium hydroxide, and water for injection.
Last reviewed on RxList: 6/14/2010




Sprix Drug Description
SPRIX™
(ketorolac tromethamine) Nasal Spray

WARNING
LIMITATIONS OF USE, GASTROINTESTINAL, BLEEDING, CARDIOVASCULAR, and RENAL RISK
Limitations of Use
SPRIX (ketorolac tromethamine), a nonsteroidal anti-inflammatory drug (NSAID),
is indicated for short-term (up to 5 days in adults) management of moderate
to moderately severe pain that requires analgesia at the opioid level. Do not
exceed a total combined duration of use of SPRIX and other ketorolac formulations
(IM/IV or oral) of 5 days [see DOSING AND ADMINISTRATION, and WARNINGS AND PRECAUTIONS].
SPRIX is not indicated for use in pediatric patients and it is not indicated
for minor or chronic painful conditions.
Gastrointestinal Risk
Ketorolac tromethamine, including SPRIX, can cause peptic ulcers, gastrointestinal
bleeding and/or perforation of the stomach or intestines, which can be fatal.
These events can occur at any time during use and without warning symptoms.
Therefore, SPRIX is contraindicated in patients with active peptic ulcer disease,
in patients with recent gastrointestinal bleeding or perforation, and in patients
with a history of peptic ulcer disease or gastrointestinal bleeding. Elderly
patients are at greater risk for serious gastrointestinal events [see CONTRAINDICATIONS,
WARNINGS AND PRECAUTIONS].
Bleeding Risk
Ketorolac tromethamine inhibits platelet function and is, therefore, contraindicated
in patients with suspected or confirmed cerebrovascular bleeding, patients with
hemorrhagic diathesis, incomplete hemostasis and those at high risk of bleeding
[see CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS].
Cardiovascular Risk
NSAIDs may cause an increased risk of serious cardiovascular thrombotic events,
myocardial infarction, and stroke, which can be fatal. This risk may increase
with duration of use. Patients with cardiovascular disease or risk factors for
cardiovascular disease may be at greater risk [see WARNINGS AND PRECAUTIONS].
SPRIX Nasal spray is contraindicated for treatment of peri-operative
pain in the setting of coronary artery bypass graft (CABG) surgery [see CONTRAINDICATIONS].
Renal Risk
SPRIX is contraindicated in patients with advanced renal impairment
and in patients at risk for renal failure due to volume depletion [see CONTRAINDICATIONS,
WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION
Ketorolac tromethamine is a member of the pyrrolo-pyrrole group of nonsteroidal
anti-inflammatory drugs (NSAIDs). The chemical name for ketorolac tromethamine
is (±)-5-benzoyl-2,3-dihydro-1Hpyrrolizine-1-carboxylic acid, compound
with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), and the structural formula
is:








The molecular weight of ketorolac tromethamine is 376.41. Ketorolac tromethamine
is highly water-soluble, allowing its formulation in an aqueous nasal spray
product at pH 7.2.
SPRIX is available as an intranasal spray product containing the active ingredient
(ketorolac tromethamine) and the excipients edetate disodium (EDTA), monobasic
potassium phosphate, sodium hydroxide, and water for injection.
Last reviewed on RxList: 6/14/2010




Sprix Drug Description
SPRIX™
(ketorolac tromethamine) Nasal Spray

WARNING
LIMITATIONS OF USE, GASTROINTESTINAL, BLEEDING, CARDIOVASCULAR, and RENAL RISK
Limitations of Use
SPRIX (ketorolac tromethamine), a nonsteroidal anti-inflammatory drug (NSAID),
is indicated for short-term (up to 5 days in adults) management of moderate
to moderately severe pain that requires analgesia at the opioid level. Do not
exceed a total combined duration of use of SPRIX and other ketorolac formulations
(IM/IV or oral) of 5 days [see DOSING AND ADMINISTRATION, and WARNINGS AND PRECAUTIONS].
SPRIX is not indicated for use in pediatric patients and it is not indicated
for minor or chronic painful conditions.
Gastrointestinal Risk
Ketorolac tromethamine, including SPRIX, can cause peptic ulcers, gastrointestinal
bleeding and/or perforation of the stomach or intestines, which can be fatal.
These events can occur at any time during use and without warning symptoms.
Therefore, SPRIX is contraindicated in patients with active peptic ulcer disease,
in patients with recent gastrointestinal bleeding or perforation, and in patients
with a history of peptic ulcer disease or gastrointestinal bleeding. Elderly
patients are at greater risk for serious gastrointestinal events [see CONTRAINDICATIONS,
WARNINGS AND PRECAUTIONS].
Bleeding Risk
Ketorolac tromethamine inhibits platelet function and is, therefore, contraindicated
in patients with suspected or confirmed cerebrovascular bleeding, patients with
hemorrhagic diathesis, incomplete hemostasis and those at high risk of bleeding
[see CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS].
Cardiovascular Risk
NSAIDs may cause an increased risk of serious cardiovascular thrombotic events,
myocardial infarction, and stroke, which can be fatal. This risk may increase
with duration of use. Patients with cardiovascular disease or risk factors for
cardiovascular disease may be at greater risk [see WARNINGS AND PRECAUTIONS].
SPRIX Nasal spray is contraindicated for treatment of peri-operative
pain in the setting of coronary artery bypass graft (CABG) surgery [see CONTRAINDICATIONS].
Renal Risk
SPRIX is contraindicated in patients with advanced renal impairment
and in patients at risk for renal failure due to volume depletion [see CONTRAINDICATIONS,
WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION
Ketorolac tromethamine is a member of the pyrrolo-pyrrole group of nonsteroidal
anti-inflammatory drugs (NSAIDs). The chemical name for ketorolac tromethamine
is (±)-5-benzoyl-2,3-dihydro-1Hpyrrolizine-1-carboxylic acid, compound
with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), and the structural formula
is:








The molecular weight of ketorolac tromethamine is 376.41. Ketorolac tromethamine
is highly water-soluble, allowing its formulation in an aqueous nasal spray
product at pH 7.2.
SPRIX is available as an intranasal spray product containing the active ingredient
(ketorolac tromethamine) and the excipients edetate disodium (EDTA), monobasic
potassium phosphate, sodium hydroxide, and water for injection.
Last reviewed on RxList: 6/14/2010




Sprix Drug Description
SPRIX™
(ketorolac tromethamine) Nasal Spray

WARNING
LIMITATIONS OF USE, GASTROINTESTINAL, BLEEDING, CARDIOVASCULAR, and RENAL RISK
Limitations of Use
SPRIX (ketorolac tromethamine), a nonsteroidal anti-inflammatory drug (NSAID),
is indicated for short-term (up to 5 days in adults) management of moderate
to moderately severe pain that requires analgesia at the opioid level. Do not
exceed a total combined duration of use of SPRIX and other ketorolac formulations
(IM/IV or oral) of 5 days [see DOSING AND ADMINISTRATION, and WARNINGS AND PRECAUTIONS].
SPRIX is not indicated for use in pediatric patients and it is not indicated
for minor or chronic painful conditions.
Gastrointestinal Risk
Ketorolac tromethamine, including SPRIX, can cause peptic ulcers, gastrointestinal
bleeding and/or perforation of the stomach or intestines, which can be fatal.
These events can occur at any time during use and without warning symptoms.
Therefore, SPRIX is contraindicated in patients with active peptic ulcer disease,
in patients with recent gastrointestinal bleeding or perforation, and in patients
with a history of peptic ulcer disease or gastrointestinal bleeding. Elderly
patients are at greater risk for serious gastrointestinal events [see CONTRAINDICATIONS,
WARNINGS AND PRECAUTIONS].
Bleeding Risk
Ketorolac tromethamine inhibits platelet function and is, therefore, contraindicated
in patients with suspected or confirmed cerebrovascular bleeding, patients with
hemorrhagic diathesis, incomplete hemostasis and those at high risk of bleeding
[see CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS].
Cardiovascular Risk
NSAIDs may cause an increased risk of serious cardiovascular thrombotic events,
myocardial infarction, and stroke, which can be fatal. This risk may increase
with duration of use. Patients with cardiovascular disease or risk factors for
cardiovascular disease may be at greater risk [see WARNINGS AND PRECAUTIONS].
SPRIX Nasal spray is contraindicated for treatment of peri-operative
pain in the setting of coronary artery bypass graft (CABG) surgery [see CONTRAINDICATIONS].
Renal Risk
SPRIX is contraindicated in patients with advanced renal impairment
and in patients at risk for renal failure due to volume depletion [see CONTRAINDICATIONS,
WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION
Ketorolac tromethamine is a member of the pyrrolo-pyrrole group of nonsteroidal
anti-inflammatory drugs (NSAIDs). The chemical name for ketorolac tromethamine
is (±)-5-benzoyl-2,3-dihydro-1Hpyrrolizine-1-carboxylic acid, compound
with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), and the structural formula
is:








The molecular weight of ketorolac tromethamine is 376.41. Ketorolac tromethamine
is highly water-soluble, allowing its formulation in an aqueous nasal spray
product at pH 7.2.
SPRIX is available as an intranasal spray product containing the active ingredient
(ketorolac tromethamine) and the excipients edetate disodium (EDTA), monobasic
potassium phosphate, sodium hydroxide, and water for injection.
Last reviewed on RxList: 6/14/2010





Other reviews about Sprix on wordpress

Big Bannocks, Kirnathons and Grands Sprix!
  by Tom Morton
I wouldn't know where to begin in describing Da Big Bannock. Suffice to say that the biggest bannock (cheese, this year) in the world is cooked. Teams compete […]


Big Bannock, boat and back in Aberdeen
  by Tom Morton
In the Beans coffee bar and an interminable wait for a large latte. Still, at least I get my half hour free internet fix, and a means of […]


Officer Chat
  by Miriella
[21:40:02] [Sprix]: he loves me [21:40:07] [Sprix]: he just is a little scared sometimes [21:40:24] [Karoo]: ugh fuck me >< [21:40:30] [Karoo]: I'm not afraid of vagina [21:40:37] [Sprix]: i know that […]


Thank you!
  by juvymacapagal
I know this blog won't be enough but I'd like to thank all those people who listened, believed, and trusted my vision for the CAS Student Council. Until now, […]


http://coryaquino.ph/
  by Jhesthee Samson
http://coryaquino.ph/ This is where other people can send their prayers and sympathy to the Aquino Family as to respect their privacy. ____________________________________________________________ this is from my yahoo messenger, a message from […]


About
  by for7un3
Title: In Development Author: Kevin Dieny Release Date: Unknown Genre: Science Fiction/Fantasy/Adventure Content: For Mature Adults Important Characters: Roage, Sible, Sprix, Astropath "A", Nemesis "N" Hello and welcome to my first attempt to write […]


Sprix Approved for Moderate-to-Severe Pain
  by nalonsospc
MONDAY, May 17 (HealthDay News) -- Roxro Pharma's Sprix (ketorolac tromethamine) nasal spray has been approved by the U.S. Food and Drug Administration for the short-term treatment of […]


Outline
  by for7un3
UPDATED: 5/28/10 STYLE: Constant flow of adrenaline mimicking expanse followed by compression of space.. DIRECTION: First detailing of capture, and characters Roage and Sprix. First arena spar with Sible, his ability used […]


Enantioselective Wacker Oxidation
  by naturalproductman
Hiroaki Sasai and co-workers at Osaka University have published in Org Lett on an enantioselective Wacker cyclization using a palladium catalyst with a SPRIX ligand. OL paper



Other reviews about Sprix on web:

SPRIX is indicated in adult patients for the short term (up to 5 days) management of moderate to moderately severe pain that requires analgesia at the opioid level. SPRIX (Ketorolac Tromethamine) Nasal Spray


Sprix (ketorolac tromethamine) is used to treat pain. Includes Sprix side effects, interactions and indications. Sprix Information from Drugs.com


(テδヲテつテつェ)テδ」テつづつケテδ」テつεつ療δ」テつεつェテδ」テつεつεδ」テつづつッテδ」テつづつケテδ」テつテつッテδッテつシテつ妥δヲテつ陛つ凖δ・テつョテつ、テδ」テつテつづδ」テつテつ淌δ」テつづつ甘δ」テつテつョテδァテつ氾つ淌δ・テつセテつ津δヲテつ陛つーテδ」テつテつァテδヲテつ療つ・テδヲテつ愿つャテδ、テつクテつテδ」テつテつョテδ・テつテつ凝δ・テつ暗つ・テδヲテつ古つテδ・テつーテつ偲δ・テつーテつづδゥテつ姪つテδ・テつ。テつセテδ」テつテつ古δヲテつ」テつョテδ・テつ。テつセテδ」テつテつ催δ」テつづつ津δゥテつテつ凝δ・テつ姪つカテδ」テつテつ療δ」テつテつテδァテつ氾つ淌δ・テつセテつ津δヲテつ陛つーテδヲテつ療つ・テδヲテつ愿つャテδ、テつクテつテδ」テつテつョテδィテつェテつュテδヲテつ崚つクテδヲテつ陛つ凖δィテつづつイテδ」テつεつ療δ」テつεつュテδ」テつづつーテδ」テつεつゥテδ」テつεつテδ」テつテつ古δ」テつづつーテδ」テつεつェテδ」テつεつ ... SPRIX


WEll, there are 2 purposes to life, first we'll explore the more important one. Sex, what else? Once you hit puberty its all you want. You could ge... Urban Dictionary: Sprix


Latest from Plurk.com Sprix shares http://images.plurk.com/3532449_612f5e77d471576e6a481d5331b5b263.jpg tentative new frat shirt design:) - View responses now Come hither, boy.


Learn about the prescription medication Sprix (Ketorolac Tromethamine Nasal Spray), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Sprix (Ketorolac Tromethamine Nasal Spray) Drug Information: Uses ...


Steam system products including steam traps for condensate removal, control valves and regulators for pressure and/or temperature control. Spirax Sarco - Knowledge, Services & Products for steam heating ...


Sprix (ketorolac tromethamine) is used to treat pain. Includes Sprix side effects, interactions and indications. Roxro Announces FDA Approval of Sprix


ROXRO ANNOUNCES FDA APPROVAL OF SPRIXテδ「テつテつ「 (Ketorolac Tromethamine)- First Non-narcotic Intranasal Analgesic for Moderate to Moderately Severe Pain MENLO PARK, CA (May 17, 2010) ... ROXRO ANNOUNCES FDA APPROVAL OF SPRIXテδ「テつテつ「


WARNING: LIMITATIONS OF USE, GASTROINTESTINAL, BLEEDING, CARDIOVASCULAR, and RENAL RISK. Limitations of Use テδ「テつテつ The total duration of use of SPRIX and other ketorolac formulations ... ROXRO Pharma





Featured Reviews

Reviews Venofer

Venofer Drug Description Venofer ® (iron sucrose) Injection, USP DRUG DESCRIPTION What are the possible side effects of iron sucrose injection (Venofer)? Get emergency medical help if you have any of these signs of an allergic...
Read More  |  Review This
Reviews Daunorubicin

Cerubidine Drug Description CERUBIDINE (daunorubicin HCl) Injection WARNING Cerubidine must be given into a rapidly flowing intravenous infusion. It must never be given by the intramuscular or subcutaneous route. Severe ...
Read More  |  Review This
Reviews Preservative-Free Heparin Lock Flush Solution

HEP-LOCK U/P Drug Description HEP-LOCK U/P Preservative-Free (Heparin Lock Flush) Solution, USP DRUG DESCRIPTION Heparin is a heterogeneous group of straight-chain anionic mucopolysaccharides, called glycosaminoglycans, having...
Read More  |  Review This
Reviews Valproic Acid

Stavzor Drug Description Stavzor (valproic acid) Delayed Release Capsules WARNING: LIFE-THREATENING ADVERSE REACTIONS Hepatotoxicity Hepatic failure resulting in fatalities has occurred in patients receiving valproic acid and its...
Read More  |  Review This
Reviews Potassium Chloride Extended Release Formulation for Liquid Suspension

Micro-K for Liquid Suspension Drug Description MICRO-KÒ LS brand of Potassium Chloride Extended Release Formulation for Liquid Suspension Rx Only DRUG DESCRIPTION Micro-K LS is an oral dosage form of microencapsulated potassium...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....